China-based TandemAI, which uses AI to speed up the design and optimization of drug candidates, raises $25M in seed and pre-Series A funding (FinSMEs)

FinSMEs:
China-based TandemAI, which uses AI to speed up the design and optimization of drug candidates, raises $25M in seed and pre-Series A funding  —  TandemAI, a Suzhou, and Shangai, China-based provider of a computational platform to accelerate the design and optimization of drug candidates, raised $25m in Seed and pre-Series A financing.